NCT01820780已完成不适用
Usefulness of a Short-time But Very Early Specialized Follow-up After Hospitalization for Acute Heart Failure: a Randomized Controlled Trial.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 507
- 试验地点
- 2
- 主要终点
- Number of participants with all cause death or unplanned hospitalization at 6 months
研究概览
简要总结
After decompensated heart failure, a number of patients have high risk of early rehospitalization as well as death. Specialized medical management for a short period but very early after discharge could be critical for optimizing care and improving early outcome.
This study aims to compare such early intensive medical management with usual care in high-risk patients after discharge.
详细描述
At discharge, high-risk HF patients are selected and randomized in two groups:
- Control group: usual disease management according to guidelines and including first medical consultation and biological test within the 4-week time following discharge.
- Active group: consultations with HF specialist including biological test at weeks 1, 2 and 4 are planned in addition to usual management.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years or more
- •consent signed
- •Acute or decompensated heart failure with one or more of following criteria::
- •Discharge BNP > 350 pg/ml or NTproBNP > 2200 pg/ml
- •Discharge serum creatinine ≥ 180µM
- •Discharge systolic blood pressure ≤ 110mmHg
- •Previous hospitalisation for acute heart failure < 6 months
排除标准
- •acute coronary syndrome,
- •acute myocarditis,
- •isolated right HF,
- •transient HF,
- •planned cardiac surgery,
- •high risk of short-term non-cardiac death,
- •planned management within rehabilitation center/HF clinic at discharge
结局指标
主要结局
Number of participants with all cause death or unplanned hospitalization at 6 months
时间窗: 6 months
次要结局
- All cause mortality at 12 months(one year)
- Natriuretic peptides blood levels at 6 months.(6 months.)
- Global cost of patient management(from day0 to 12 months)
- Analysis of subgroups (LVEF altered or not, first HF episode or not, age> or ≤ 75, Changes in levels of BNP or NT-proBNP between day0 and the second consultation in the active group: ≥ 30% decrease, ≥ 30% increase, Intermediate variation).(6 months)
- Number of alive and hospitalization-free days at 6 and 12 months(6 and 12 months)
- Mean and distribution modified Goldman classe at 6 months(6 months)
- Unplanned HF-related hospitalization at 6 and 12 months(6 and 12 months)
- Biomarkers measured in plasma collected at day0: predictive value of the risk of death and hospitalization during the period of 6 months(6 months)
- HF-treatment at 6 months(6 months)
- Mean and distribution NYHA classe at 6 months(6 months)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
1 期
TREASURE trialCTIS2022-503135-33-00niversity Hospital Maastricht130
已完成
不适用
DEventer-ALkmaar Heart failure Project.NL-OMON24472Funding/Support: This study was financially supported by a grant from Novartis Pharma BV, AstraZeneca BV, Bristol-Myers Squibb BV. Roche Diagnostics provided the test essays for NT-proBNP.Role of sponsors: The funding source for this study played no role in the design or conduct of the study; data management and analysis; or manuscript preparation, review, and authorisation for submission.240
招募中
不适用
Dapa Acute Heart Failure StudyHeart FailureNCT05759000Chinese University of Hong Kong100
Unknown
4 期
Effectiveness of a Repetitive Use of 24-hour Levosimendan Infusions in Patients With Severe Systolic Heart Failure in Order to Prevent RehospitalizationsSystolic Heart FailureNCT03764722Collegium Medicum w Bydgoszczy100
Unknown
不适用
Optimize Heart Failure Care During TRANSitional Period in Patients With Acute Heart Failure.Heart Failure With Reduced Ejection FractionAcute Heart FailureNCT04900584Wonju Severance Christian Hospital1,009